Peter Attia· MD
either it is a benign lesion like a fibro adoma or a pre or even a pre precancerous change in the breast that might warrant additional followup or surveillance
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
either it is a benign lesion like a fibro adoma or a pre or even a pre precancerous change in the breast that might warrant additional followup or surveillance
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it it turns out to be very reassuring that either it is a benign lesion like a fibro adoma or a pre or even a pre pre cancerous change in the breast that might warrant additional followup or surveillance uh but is not truly breast cancer